Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

A new compound shows promise as a topical treatment for hair loss.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib significantly improved skin and hair conditions without side effects.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

Ocrelizumab may cause pancreatitis in some patients.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Centipeda minima and brevilin A protect skin cells from damage and aging.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.